What do we do?
We’re looking for researchers who have new ideas in:
01
Reproductive medicine
Reproductive medicine is a branch of medicine concerned with the male and female reproductive systems. It covers their prevention and evaluation, as well as their subsequent treatment and prognosis. Recently it has seen massive advances with the help of technology and research.
02
Genomics
Genomics is an interdisciplinary field of biology that focuses on the genome, the complete set of DNA, including all of its genes. The genomics market is gaining ground because of its applications in various fields of study. In this era of medical and life science innovations that are shaped as an inevitable adoption for the sustainability of humanity, genomics research is poised for exponential growth because of the imperative genetic innovations that feed on it.
03
Medical devices
A medical device is any device intended to be used for medical purposes. They benefit patients by helping health care providers diagnose and treat patients and help them overcome illness or disease, improving their quality of life.
04
– Drug discovery
– Artificial Intelligence
– Diagnosis
– Telemedicine
– Consumer products
What do we offer?
How we help researchers:
Scientific advice
From the launch to the implementation of the project
Investors
We help find investors and have our own capital for seed phases.
Partners
We advise on how to deal with
with the new partners.
Management
How to manage the new company efficiently and professionally.
Operations
We have specialists in intellectual property, legal and financial advice.
Facilities
We offer our own facilities: offices and access to laboratory.
Join the HOMU community of experts and obtain a substantial competitive advantage.
Our vision
Build and guide the largest cluster of innovative fertility and reproductive startups.
Mission statement
Create the largest worldwide innovative startup ecosystem that being part of them represents having a substantial competitive advantage.
GAP
There is a need in the fertility sector of an ecosystem that nurtures early-stage concepts to viable start-ups.
Sama
United States
Sama is the nation’s first fertility clinic providing fertility care from anywhere. With SAMA technology-driven cycle management platform, they’re building fertility care around patients’ lives, not the other way around.
Rosa scientific
United States
Solution to decentralize IVF by offering at-home monitoring and using local doctors, thus optimizing costs and increasing accessibility.
Butterfly
United States
At Butterfly Biosciences, we have created a single platform to diagnose and treat most conditions that impact gynecologic and reproductive health. Creating an in-office solution that replaces surgery to perform most operative-based intrauterine treatments with less invasive, less expensive, and more effective treatment sets.
EmbryoCloud
European Union
New embryo culture media that resembles the natural environment by including biological fluid components. In bovine it reduces the risk of large-calf syndrome and increases IVF pregnancy rates.
Incintas
United States
Improves endometrial receptivity by delivering Progesterone directly into the woman's uterus and releasing it gradually.
Genótica
European Union
First marketplace to compare more than 1000 genetic tests from international
Plus Vitech
European Union
Metastatic Cancer treatment using NK1R inhibitor
Synchrony App
European Union
Application that SYNCHRONIZES the patient, doctor and embryologist obtaining the best embryo transfer coordination.
NDOM
European Union
Implementing advanced non-invasive diagnostic methods and the first therapeutic solution for endometriosis.
GenEmbryomics
Australia
Complete genome sequencing of the embryo to detect any type of abnormality, including de novo mutations not present in the parents
Arediana
European Union
Arediana is a Digital Native Brand (DNB) born to improve Women’s Health in all their life moments through friendly and referred content, ethical and science-based food supplements, and a strong Healthcare Professionals and Consumers Community.
Matris
Canada
Matris™ is an innovative test that evaluates endometrial receptivity in patients undergoing ART. Matris™ uses proprietary algorithms and specialized technologies to assess and interpret ultrasonographic images taken by the clinic.
Using 2- and 3-dimensional techniques, Matris™ and our team generate insights into endometrial receptivity that cannot be detected in routine clinical practice.
Youngr
United States
AGING: Marketplace for medically proven products and services to keep you yong.
Antiviral Protection
European Union
VIROLOGY: Ready to commercialize anti-viral coating for surfaces in public spaces.
OUR companies
Portfolio:
Reproductive Health
Rosa scientific
United States
Solution to decentralize IVF by offering at-home monitoring and using local doctors, thus optimizing costs and increasing accessibility.
Butterfly
United States
At Butterfly Biosciences, we have created a single platform to diagnose and treat most conditions that impact gynecologic and reproductive health. Creating an in-office solution that replaces surgery to perform most operative-based intrauterine treatments with less invasive, less expensive, and more effective treatment sets.
EmbryoCloud
European Union
New embryo culture media that resembles the natural environment by including biological fluid components. In bovine it reduces the risk of large-calf syndrome and increases IVF pregnancy rates.
Incintas
United States
Improves endometrial receptivity by delivering Progesterone directly into the woman’s uterus and releasing it gradually.
Genótica
European Union
First marketplace to compare more than 1000 genetic tests from international
Plus Vitech
European Union
Metastatic Cancer treatment using NK1R inhibitor.
Synchrony App
European Union
Application that SYNCHRONIZES the patient, doctor and embryologist obtaining the best embryo transfer coordination.
Sama
United States
Sama is the nation’s first fertility clinic providing fertility care from anywhere. With SAMA technology-driven cycle management platform, they’re building fertility care around patients’ lives, not the other way around.
NDOM
European Union
Implementing advanced non-invasive diagnostic methods and the first therapeutic solution for endometriosis.
GenEmbryomics
Australia
Complete genome sequencing of the embryo to detect any type of abnormality, including de novo mutations not present in the parents
Arediana
European Union
Arediana is a Digital Native Brand (DNB) born to improve Women’s Health in all their life moments through friendly and referred content, ethical and science-based food supplements, and a strong Healthcare Professionals and Consumers Community.
Matris
Canada
Matris™ is an innovative test that evaluates endometrial receptivity in patients undergoing ART. Matris™ uses proprietary algorithms and specialized technologies to assess and interpret ultrasonographic images taken by the clinic.
Using 2- and 3-dimensional techniques, Matris™ and our team generate insights into endometrial receptivity that cannot be detected in routine clinical practice.
Other verticals
Youngr
AGING: Marketplace for medically proven products and services to keep you yong.
Antiviral Protection
VIROLOGY: Ready to commercialize anti-viral coating for surfaces in public spaces.
Partners:
Track record:
MedAnswers
financed with venture capital
Phosphorus
financed with venture capital
FullGenomics
Founded by our founders
Press:
Venture capital and private equity firms that have invested in our companies
Who we are
Our team members
Co-founders:
Dr. Santiago Munne
PhD in Human Genetics from the University of Pittsburgh and a degree in Biology from the Autonomous University of Barcelona. CIO at Overture Life. Founder of: Reprogenetics, Recombine, Phosphorus, MedAnswers, Overture Life, G1 Sciences. Advisory Board (currently): Overture Life, Phosphorus, MedAnswers, Butterfly, Sama & Genembryonics.
Dr. José Horcajadas
PhD in Molecular Biology and Biochemistry from the Autonomous University of Madrid. He has solid experience in the field of Human Reproduction Genetics, especially in the area of endometrial receptivity, genomics, transcriptomics, implantation and embryo viability.
Dr. David Cotán
Doctor in Biotechnology and Degree in Environmental Sciences from the University Pablo de Olavide (Seville). Entrepreneur, specialized in technical direction and project management in the field of rare diseases, reproduction and enzyme scaling in the Andalusian Centre for Developmental Biology.
Delfí Torns
CEO Programme by IESE, MBA by la Salle University, Bachelor of Arts Degree by UOC, Business studies degree and Tourism business studies by the University of Barcelona. More than 25 years of executive experience, half of them as Managing Director. Active business angel, writer, business consultant, and independent advisor.
Advisors:
Aida Montes
David Boronat
Degree in Business Administration by ESADE and Master in International Business by British Columbia University. Founder and Executive President at Multiplica – one of the best known Spanish-speaking digital consulting firms – and renowned internet expert with a long career as a consultant, teacher, and speaker and author of several books, as well as active business angel.
Daniel Oliver
Daniel (Biologist, Universitat de Barcelona) is the founder and director of Capital Cell and a specialist in early-stage Biotech investment. He has participated in over 50 successful investment rounds totalling well over 35 million euro since 2015 and is one of the leading experts both in equity crowdfunding and in Life Sciences startup investment in Spain.
Our impact
As professors and influencers, we are in touch with the main Universities in Spain and the US
Yale University – CTUS, US
University of Pittsburgh – PAUS, US
EVMS (Eastern Virginia Medical School), US.
UAM (Universidad Autónoma de Madrid), Spain.
UPO (Universidad Pablo de Olavide), Spain.
UJA (Universidad de Jaen), Spain.
UAB (Universitat Autònoma de Barcelona) & UB (Universidad Barcelona), Spain.
UAM (Universidad Autónoma de Murcia), Spain.
Universidad de la Plata, Argentina
Rio Grande do Sur, Brazil
We are members of several international health & management associations:
ESHRE – ASRM – ASEBIR – SEF – PGEDIS
COGEN – PCRS – ACOG – ASHC
YPO (Young President Organization)
